The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Natural products to drugs: daptomycin and related lipopeptide antibiotics
Abstract
Daptomycin (Cubicin) is a lipopeptide antibiotic approved in the USA in 2003 for the treatment of skin and skin structure infections caused by Gram-positive pathogens. It is a member of the 10-membered cyclic lipopeptide family of antibiotics that includes A54145, calcium-dependent antibiotic (CDA), amphomycin, friulimicin, laspartomycin, and others. This review highlights research on this class of antibiotics from 1953 to 2005, focusing on more recent studies with particular emphasis on the interplay between structural features and antibacterial activities; chemical modifications to improve activity; the genetic organization and biosynthesis of lipopeptides; and the genetic engineering of the daptomycin biosynthetic pathway to produce novel derivatives for further chemical modification to develop candidates for clinical evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)
Bentley, S. D., Chater, K. F., Cerdeño-Tárraga, A.-M., Challis, G. L., Thomson, N. R., James, K. D., Harris, D. E., Quail, M. A., Kieser, H., Harper, D., et al. (2002) · Nature · doi:10.1038/417141a · Cited by 3,233
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases
Stachelhaus, T., Mootz, H. D., & Marahiel, M. A. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80082-9 · Cited by 1,237
Shaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.1.138-163.1993 · Cited by 1,196
Modular Peptide Synthetases Involved in Nonribosomal Peptide Synthesis
Marahiel, M. A., Stachelhaus, T., & Mootz, H. D. (1997) · Chemical Reviews · doi:10.1021/cr960029e · Cited by 1,126
Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042683 · Cited by 1,053
Tillett, D., Dittmann, E., Erhard, M., von Döhren, H., Börner, T., & Neilan, B. A. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00021-1 · Cited by 995
Biosynthesis of Nonribosomal Peptides
Finking, R., & Marahiel, M. A. (2004) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123615 · Cited by 888
Bender, C. L., Alarcón-Chaidez, F., & Gross, D. C. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.2.266-292.1999 · Cited by 839
Regulation of secondary metabolism in streptomycetes
Bibb, M. J. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.02.016 · Cited by 821
Challis, G. L., Ravel, J., & Townsend, C. A. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00091-0 · Cited by 806
Arbeit, R. D., Maki, D., Tally, F. P., Campanaro, E., Eisenstein, B. I., & Daptomycin 98-01 and 99-01 Investigators (2004) · Clinical Infectious Diseases · doi:10.1086/420818 · Cited by 689
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Three-Year Surveillance of Community-AcquiredStaphylococcus aureus Infections in Children
Kaplan, S. L., Hulten, K. G., Gonzalez, B. E., Hammerman, W. A., Lamberth, L., Versalovic, J., & Mason, E. O. (2005) · Clinical Infectious Diseases · doi:10.1086/430312 · Cited by 602
Nonribosomal peptides: from genes to products
Schwarzer, D., Finking, R., & Marahiel, M. A. (2003) · Natural Product Reports · doi:10.1039/b111145k · Cited by 585
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 561
Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact
Silverman, J. A., Mortin, L. I., VanPraagh, A. D. G., Li, T., & Alder, J. (2005) · The Journal of Infectious Diseases · doi:10.1086/430352 · Cited by 541
Mootz, H. D., Schwarzer, D., & Marahiel, M. A. (2002) · ChemBioChem · doi:10.1002/1439-7633(20020603)3:6<490::aid-cbic490>3.0.co;2-n · Cited by 514
Vancomycin-Resistant Staphylococcus aureus Isolate from a Patient in Pennsylvania
Tenover, F. C., Weigel, L. M., Appelbaum, P. C., McDougal, L. K., Chaitram, J., McAllister, S., Clark, N., Killgore, G., O'Hara, C. M., Jevitt, L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.275-280.2004 · Cited by 370
Miao, V., Coëffet-LeGal, M.-F., Brian, P., Brost, R., Penn, J., Whiting, A., Martin, S., Ford, R., Parr, I., Bouchard, M., et al. (2005) · Microbiology · doi:10.1099/mic.0.27757-0 · Cited by 368
Self-citationPeptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase
Trauger, J. W., Kohli, R. M., Mootz, H. D., Marahiel, M. A., & Walsh, C. T. (2000) · Nature · doi:10.1038/35025116 · Cited by 329
Sequence and analysis of the genetic locus responsible for surfactin synthesis in Bacillus subtilis
Cosmina, P., Rodriguez, F., de Ferra, F., Grandi, G., Perego, M., Venema, G., & van Sinderen, D. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01629.x · Cited by 307
Walsh, C. T., Chen, H., Keating, T. A., Hubbard, B. K., Losey, H. C., Luo, L., Marshall, C. G., Miller, D. A., & Patel, H. M. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00235-0 · Cited by 301
Structural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin
Jung, D., Rozek, A., Okon, M., & Hancock, R. E. W. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.020 · Cited by 297
Mechanisms of action of newer antibiotics for Gram-positive pathogens
Hancock, R. E. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70051-7 · Cited by 295
Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic
van Wageningen, A. A., Kirkpatrick, P. N., Williams, D. H., Harris, B. R., Kershaw, J. K., Lennard, N. J., Jones, M., Jones, S. J. M., & Solenberg, P. J. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90060-6 · Cited by 290
Biomimetic synthesis and optimization of cyclic peptide antibiotics
Kohli, R. M., Walsh, C. T., & Burkart, M. D. (2002) · Nature · doi:10.1038/nature00907 · Cited by 287
Du, L., Sánchez, C., Chen, M., Edwards, D. J., & Shen, B. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00011-9 · Cited by 282
Skinner, R., Cundliffe, E., & Schmidt, F. J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44232-3 · Cited by 263
Daptomycin‐Resistant, Methicillin‐Resistant Staphylococcus aureus Bacteremia
Mangili, A., Bica, I., Snydman, D. R., & Hamer, D. H. (2005) · Clinical Infectious Diseases · doi:10.1086/428616 · Cited by 256
Weber, G., Schörgendorfer, K., Schneider-Scherzer, E., & Leitner, E. (1994) · Current Genetics · doi:10.1007/bf00313798 · Cited by 256
Robinson, D. A., Kearns, A. M., Holmes, A., Morrison, D., Grundmann, H., Edwards, G., O'Brien, F. G., Tenover, F. C., McDougal, L. K., Monk, A. B., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74814-5 · Cited by 256
Glycopeptide Antibiotic Resistance Genes in Glycopeptide-Producing Organisms
Marshall, C. G., Lessard, I. A. D., Park, I.-S., & Wright, G. D. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2215 · Cited by 252
Resistance Studies with Daptomycin
Silverman, J. A., Oliver, N., Andrew, T., & Li, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1799-1802.2001 · Cited by 234
Bozdogan, B. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg457 · Cited by 225
Daptomycin disrupts membrane potential in growing Staphylococcus aureus
Alborn, W. E., Allen, N. E., & Preston, D. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2282 · Cited by 213
Regeneration of misprimed nonribosomal peptide synthetases by type II thioesterases
Schwarzer, D., Mootz, H. D., Linne, U., & Marahiel, M. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212382199 · Cited by 210
Emergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin Therapy
Sabol, K., Patterson, J. E., Lewis, J. S., Owens, A., Cadena, J., & Jorgensen, J. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1664-1665.2005 · Cited by 209
Huang, J., Lih, C.-J., Pan, K.-H., & Cohen, S. N. (2001) · Genes & Development · doi:10.1101/gad.943401 · Cited by 208
Daptomycin: a novel agent for Gram-positive infections
Tally, F. P., Zeckel, M., Wasilewski, M. M., Carini, C., Berman, C. L., Drusano, G. L., & Oleson JR, F. B. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.8.1223 · Cited by 205
DEBONO, M., ABBOTT, B. J., MOLLOY, R. M., FUKUDA, D. S., HUNT, A. H., DAUPERT, V. M., COUNTER, F. T., OTT, J. L., CARRELL, C. B., HOWARD, L. C., et al. (1988) · The Journal of Antibiotics · doi:10.7164/antibiotics.41.1093 · Cited by 203
Once-Daily Dosing in Dogs Optimizes Daptomycin Safety
Oleson, F. B., Berman, C. L., Kirkpatrick, J. B., Regan, K. S., Lai, J.-J., & Tally, F. P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.2948-2953.2000 · Cited by 196
Pootoolal, J., Thomas, M. G., Marshall, C. G., Neu, J. M., Hubbard, B. K., Walsh, C. T., & Wright, G. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102285099 · Cited by 185
A combined genetic and physical map of the Streptomyces coelicolor A3(2) chromosome
Kieser, H. M., Kieser, T., & Hopwood, D. A. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.17.5496-5507.1992 · Cited by 180
Hubbard, B. K., Thomas, M. G., & Walsh, C. T. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00043-0 · Cited by 176
In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic
Eliopoulos, G. M., Willey, S., Reiszner, E., Spitzer, P. G., Caputo, G., & Moellering, R. C. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.4.532 · Cited by 173
Pharmacodynamics of Daptomycin in a Murine Thigh Model of Staphylococcus aureus Infection
Louie, A., Kaw, P., Liu, W., Jumbe, N., Miller, M. H., & Drusano, G. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.845-851.2001 · Cited by 172
Production of hybrid glycopeptide antibiotics in vitro and in Streptomyces toyocaensis
Solenberg, P. J., Matsushima, P., Stack, D. R., et al. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90288-x · Cited by 169
Identification and characterization of novel pyoverdine synthesis genes in Pseudomonas aeruginosa
Lamont, I. L., & Martin, L. W. (2003) · Microbiology · doi:10.1099/mic.0.26085-0 · Cited by 169
Barry, A. L., FUCHS, P. C., & Brown, S. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1919-1922.2001 · Cited by 158
Hahn, M., & Stachelhaus, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404932101 · Cited by 157
Woodworth, J. R., Nyhart, E. H., Brier, G. L., Wolny, J. D., & Black, H. R. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.318 · Cited by 155
Konz, D., Doekel, S., & Marahiel, M. A. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.1.133-140.1999 · Cited by 154
Unusual enzymes involved in five pathways of glutamate fermentation
Buckel, W. (2001) · Applied Microbiology and Biotechnology · doi:10.1007/s002530100773 · Cited by 152
Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032
Allen, N. E., Hobbs, J. N., & Alborn, W. E. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1093 · Cited by 151
Canepari, P., Boaretti, M., Lleò, M. M., et al. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1220 · Cited by 148
Schneider, A., & Marahiel, M. A. (1998) · Archives of Microbiology · doi:10.1007/s002030050590 · Cited by 143
Aerobic tryptophan degradation pathway in bacteria: novel kynurenine formamidase
Kurnasov, O. V., Jablonski, L. M., Polanuyer, B. M., Dorrestein, P. C., Begley, T. P., & Osterman, A. L. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00684-0 · Cited by 142
Membrane potential and gentamicin uptake in Staphylococcus aureus.
Mates, S. M., Eisenberg, E. S., Mandel, L., Patel, L. R., Kaback, H. R., & Miller, M. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.21.6693 · Cited by 141
Thomas, M. G., Chan, Y. A., & Ozanick, S. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2823-2830.2003 · Cited by 141
Formation of β-Hydroxy Histidine in the Biosynthesis of Nikkomycin Antibiotics
Chen, H., Hubbard, B. K., O'Connor, S. E., & Walsh, C. T. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00090-x · Cited by 135
Synthesis and Derivatization of Daptomycin: A Chemoenzymatic Route to Acidic Lipopeptide Antibiotics
Grünewald, J., Sieber, S. A., Mahlert, C., et al. (2004) · Journal of the American Chemical Society · doi:10.1021/ja045455t · Cited by 134
Sakoulas, G., Eliopoulos, G. M., Alder, J. D., & Eliopoulos, C. T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1714-1718.2003 · Cited by 133
Choroba, O. W., Williams, D. H., & Spencer, J. B. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000076v · Cited by 132
Hesketh, A. R., Chandra, G., Shaw, A. D., Rowland, J. J., Kell, D. B., Bibb, M. J., & Chater, K. F. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03219.x · Cited by 130
Lakey, J. H., & Ptak, M. (1988) · Biochemistry · doi:10.1021/bi00413a009 · Cited by 130
Healy, F. G., Krasnoff, S. B., Wach, M. J., Gibson, D. M., & Loria, R. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.7.2019-2029.2002 · Cited by 125
Lamp, K. C., Rybak, M. J., Bailey, E. M., & Kaatz, G. W. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2709 · Cited by 124
Lee, C., Kim, S. J., Jeong, D. G., Lee, S. M., & Ryu, S. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210385200 · Cited by 124
Dandekar, P. K., Tessier, P. R., Williams, P., Nightingale, C. H., & Nicolau, D. P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg337 · Cited by 119
Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci
Rand, K. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh104 · Cited by 114
Substrate recognition by nonribosomal peptide synthetase multi-enzymes
Lautru, S., & Challis, G. L. (2004) · Microbiology · doi:10.1099/mic.0.26837-0 · Cited by 110
Stassi, D. L., Donadio, S., Staver, M. J., & Katz, L. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.182-189.1993 · Cited by 109
Cottagnoud, P., Pfister, M., Acosta, F., Cottagnoud, M., Flatz, L., Kühn, F., Müller, H.-P., & Stucki, A. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3928-3933.2004 · Cited by 109
Vértesy, L., Ehlers, E., Kogler, H., Kurz, M. E., Meiwes, J., SEIBERT, G., VOGEL, M., & Hammann, P. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.816 · Cited by 104
Ryding, N. J., Anderson, T. B., & Champness, W. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.3.794-805.2002 · Cited by 103
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic
Eliopoulos, G. M., Thauvin, C., Gerson, B., & Moellering, R. C. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.357 · Cited by 102
de Bentzmann, S., Tristan, A., Étienne, J., Brousse, N., Vandenesch, F., & Lina, G. (2004) · The Journal of Infectious Diseases · doi:10.1086/424521 · Cited by 96
Lauer, B., Russwurm, R., Schwarz, W., Kalmanczhelyi, A., Bruntner, C., Rosemeier, A., & Bormann, C. (2001) · Molecular and General Genetics MGG · doi:10.1007/s004380000352 · Cited by 94
Khaw, L. E., Böhm, G. A., Metcalfe, S. M., Staunton, J., & Leadlay, P. F. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.4.809-814.1998 · Cited by 91
Biosynthesis of microcystin-LR. Origin of the carbons in the adda and masp units
Moore, R. E., Chen, J. L., Moore, B. S., Patterson, G. M. L., & Carmichael, W. W. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00013a066 · Cited by 88
Laganas, V. A., Alder, J. D., & Silverman, J. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2682-2684.2003 · Cited by 87
LAWRENCE, C. C., Sobey, W. J., Field, R. A., Baldwin, J. E., & Schofield, C. J. (1996) · Biochemical Journal · doi:10.1042/bj3130185 · Cited by 86
Eisenberg, E. S., Mandel, L., Kaback, H. R., & Miller, M. H. (1984) · Journal of Bacteriology · doi:10.1128/jb.157.3.863-867.1984 · Cited by 84
Aretz, W., Meiwes, J., SEIBERT, G., Vobis, G., & Wink, J. M. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.807 · Cited by 81
Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections
Eisenstein, B. I. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1159 · Cited by 79
Vandenende, C., Vlasschaert, M., & Seah, S. Y. K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.17.5596-5602.2004 · Cited by 75
König, A., Schwecke, T., Molnár, I., Böhm, G. A., Lowden, P. A. S., Staunton, J., & Leadlay, P. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00526.x · Cited by 74
Ikai, H., & Yamamoto, S. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.16.5118-5125.1997 · Cited by 73
Sader, H. S., Streit, J. M., Fritsche, T. R., & Jones, R. N. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.07.002 · Cited by 73
Biosynthesis and Molecular Genetics of Clavulanic Acid
Jensen, S. E., & Paradkar, A. S. (1999) · Antonie van Leeuwenhoek · doi:10.1023/a:1001755724055 · Cited by 72
Daptomycin – a novel antibiotic against Gram-positive pathogens
LaPlante, K. L., & Rybak, M. J. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.11.2321 · Cited by 72
Banerjee, D. K., Scher, M. G., & Waechter, C. J. (1981) · Biochemistry · doi:10.1021/bi00509a024 · Cited by 66
Banerjee, D. K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94136-0 · Cited by 65
Chen, H., Thomas, M. G., O'Connor, S. E., Hubbard, B. K., Burkart, M. D., & Walsh, C. T. (2001) · Biochemistry · doi:10.1021/bi0115434 · Cited by 65
ABC transporters in antibiotic-producing actinomycetes
Méndez, C., & Salas, J. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb12792.x · Cited by 64
Kaatz, G. W., Seo, S. M., Reddy, V. N., et al. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2081 · Cited by 61
S�ssmuth, R., & Wohlleben, W. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1443-z · Cited by 61
Reimmann, C., Patel, H. M., Walsh, C. T., & Haas, D. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.19.6367-6373.2004 · Cited by 57
Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin
Hill, J., Siedlecki, J. M., Parr, I. B., Morytko, M. J., Yu, X., Zhang, Y., Silverman, J. A., Controneo, N., Laganas, V. A., Li, T., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.019 · Cited by 55
Severin, A. I., Wu, S. W., Tabei, K., & Tomasz, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4566-4573.2004 · Cited by 51
ABC transporters in antibiotic-producing actinomycetes
Méndez, C. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(97)00434-5 · Cited by 49
Yin, X., O’Hare, T., Gould, S. J., & Zabriskie, T. M. (2003) · Gene · doi:10.1016/s0378-1119(03)00617-6 · Cited by 47
Ramos, M. C., Grayson, M. L., Eliopoulos, G. M., & Bayer, A. S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1864 · Cited by 43
Array synthesis of novel lipodepsipeptide
Siedlecki, J. M., Hill, J., Parr, I. B., Xiang, Y., Morytko, M. J., Zhang, Y., Silverman, J. A., Controneo, N., Laganas, V. A., Li, T., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.025 · Cited by 38
Scanning Electronmicroscopy of Staphylococcus Aureus and Enterococcus Faecalis Exposed to Daptomycin
Wale, L. J., Shelton, A. P., & Greenwood, D. R. (1989) · Journal of Medical Microbiology · doi:10.1099/00222615-30-1-45 · Cited by 36
Lakey, J. H., & LEA, E. J. A. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90217-8 · Cited by 34
Biosynthesis of trans-4-hydroxy-L-proline by Streptomyces griseoviridus.
Katz, E., Kamal, F., & Mason, K. T. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50423-3 · Cited by 32
Factor inhibiting hypoxia-inducible factor (FIH) and other asparaginyl hydroxylases
Lancaster, D. E., McDonough, M. A., & Schofield, C. J. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320943 · Cited by 32
Heinzelmann, E., Berger, S., Müller, C., Härtner, T., Poralla, K., Wohlleben, W., & Schwartz, D. (2005) · Microbiology · doi:10.1099/mic.0.27844-0 · Cited by 32
Reactive sulphur species in oxidative signal transduction
Jacob, C., Lancaster, J. R., & Giles, G. I. (2004) · Biochemical Society Transactions · doi:10.1042/bst0321015 · Cited by 31
Alder, J. D., Li, T., Yu, D., Morton, L., Silverman, J. A., Zhang, X.-X., Critchley, I. A., & Thorne, G. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3561-3566.2003 · Cited by 31
Grgurina, I., & Mariotti, F. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01528-8 · Cited by 29
Identification of daptomycin-binding proteins in the membrane of Enterococcus hirae
Boaretti, M., & Canepari, P. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.2068 · Cited by 28
Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032
Dong, M. Y., Chang, T.-W., & Gorbach, S. L. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1135 · Cited by 21
On Glumamycin, a New Antibiotic. VI. An Approach to the Amino Acid Sequence
Fujino, M. (1965) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.38.517 · Cited by 19
CONFIGURATION OF THE β-METHYLASPARTIC ACID RESIDUE IN AMPHOMYCIN
Bodanszky, M., & MARCONI, G. G. (1970) · The Journal of Antibiotics · doi:10.7164/antibiotics.23.238 · Cited by 12
Maget‐Dana, R., Lakey, J. H., & Ptak, M. (1988) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(88)90160-9 · Cited by 7
Cited by
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Microbial biosurfactants production, applications and future potential
Banat, I. M., Franzetti, A., Gandolfi, I., Bestetti, G., Martinotti, M. G., Fracchia, L., Smyth, T. J., & Marchant, R. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2589-0 · Cited by 1,474
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
New antibiotics from bacterial natural products
Clardy, J., Fischbach, M. A., & Walsh, C. T. (2006) · Nature Biotechnology · doi:10.1038/nbt1266 · Cited by 615
Small Bioactive Peptides for Biomaterials Design and Therapeutics
Hamley, I. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00522 · Cited by 461
Metadata
- Authors
- Baltz, R. H., Miao, V., & Wrigley, S. K.
- Venue
- Natural Product Reports
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2005
- Volume
- 22
- Issue
- 6
- Pages
- 717
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- OpenAlex
- W2133399253
- Cited by
- 393
- References
- 118
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.